Tumor Suppressors p53, p63TAα, p63TAy, p73α, and p73β Use Distinct Pathways to Repress Telomerase Expression

The association between non-Hodgkin lymphoma and methylation of p73

(2011) Jing-Hong Pei et al.   TUMOR BIOLOGY

Wilms' tumour 1 can suppress hTERT gene expression and telomerase activity in clear cell renal cell carcinoma via multiple pathways

(2010) R T Sitaram et al.   BRITISH JOURNAL OF CANCER

Telomeres and telomerase in cancer

(2009) S. E. Artandi et al.   CARCINOGENESIS

Transcriptional Activation ofhTERT, the Human Telomerase Reverse Transcriptase, by Nuclear Factor of Activated T Cells

(2009) Amel Chebel et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Central role of PI3K in transcriptional activation of hTERT in HTLV-I-infected cells

(2008) M. Bellon et al.   BLOOD

Telomeres, stem cells, and hematology

(2008) P. M. Lansdorp   BLOOD

Regulation of Telomerase and Telomeres: Human Tumor Viruses Take Control

(2008) M. Bellon et al.   JNCI-Journal of the National Cancer Institute

Transcriptional activation of the tumor suppressor and differentiation gene S100A2 by a novel p63-binding site

(2008) Ralf D. Kirschner et al.   NUCLEIC ACIDS RESEARCH

A balance between NF-Y and p53 governs the pro- and anti-apoptotic transcriptional response

(2008) Paolo Benatti et al.   NUCLEIC ACIDS RESEARCH